Amedisys INC 8-K filings

Amedisys, Inc. has completed its merger with UnitedHealth Group, becoming a wholly-owned subsidiary and delisting from Nasdaq, with shareholders receiving $101 per share in cash.

Amedisys and UnitedHealth Group reached a proposed final judgment with the U.S. Department of Justice and several states, clearing a significant hurdle for their merger, pending judicial approval and required divestitures.

Amedisys, Inc. announced increased adjusted revenue and profitability for the second quarter of 2025, despite a GAAP net income decline driven by significant merger-related expenses and ongoing regulatory challenges to its proposed acquisition by UnitedHealth Group.

Amedisys has entered into agreements to sell certain home health and hospice care centers to BrightSpring Health Services and The Pennant Group, contingent upon the completion of its merger with UnitedHealth Group.

Amedisys extends its credit facility maturity to July 2027 and reports increased net service revenue and adjusted EBITDA for the first quarter of 2025.

Amedisys reports a net loss for Q4 2024, impacted by merger-related expenses and impairment charges, while annual net income improves compared to the previous year.

Amedisys and UnitedHealth Group have terminated their agreement to sell certain home health care centers to VCG Luna, an affiliate of VitalCaring Group, with a mutual release of claims.

Amedisys Inc. held its annual meeting on December 30, 2024, where stockholders elected nine directors, ratified the selection of KPMG LLP as auditors, and approved executive compensation on an advisory basis.

Amedisys and UnitedHealth Group have agreed to a waiver, extending the merger deadline and modifying certain terms due to ongoing regulatory challenges.

Amedisys reported a revenue increase but a slight adjusted EBITDA increase for the third quarter of 2024, while navigating merger-related expenses and a pending acquisition by UnitedHealth Group.

Amedisys Inc. disclosed the departure of its Chief Information Officer, Michael P. North, effective August 31, 2024, along with a severance payment of $3,310,717.

Amedisys announced its Q2 2024 financial results, showing increased revenue and net income compared to the previous year, while a merger with UnitedHealth Group is pending.

Amedisys, Inc. has entered into an agreement to sell certain home health care centers to VCG Luna, LLC, contingent on the completion of its merger with UnitedHealth Group.

Amedisys reported a slight increase in revenue but a decrease in net income for the first quarter of 2024, while also navigating a pending merger with UnitedHealth Group.

The Oregon Health Authority has initiated a comprehensive review of UnitedHealth Group's proposed acquisition of Amedisys, potentially impacting the deal's timeline.

Amedisys reported a slight increase in net service revenue for both the fourth quarter and full year 2023, but experienced a net loss for the year due to merger-related costs.